Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Elongin B pseudogene 1 (ELOBP1)
- Target
- ELOBP1
- Molecular classification
- Other (Pseudogene)
01
Overview
Elongin B pseudogene 1 (ELOBP1) is a non-coding genomic element classified as a pseudogene. It shares sequence similarity with the functional gene encoding elongin B (ELOB), but lacks the necessary sequence features for protein-coding and is not expressed as a functional protein. Pseudogenes are generally considered non-functional remnants of gene duplication or retrotransposition and are not targets for drug development or pharmacological intervention[5].
- Other names
- TCEB2P1transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B) pseudogene 1transcription elongation factor B subunit 2 pseudogene 1ELOBP1
Beyond the preview
Go deeper on Elongin B pseudogene 1 (ELOBP1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Elongin B pseudogene 1 (ELOBP1).